Test | Result | |||
---|---|---|---|---|
Before transfusion | Immediately after transfusion | 5 wk after transfusion | 8 wk after transfusion | |
HTLV I/II | ||||
ELISA | Nonreactive* | Reactive† | NT | Nonreactive |
INNO-LIA | NT | Positive | NT | Negative |
RIPA | NT | Indeterminate | NT | NT |
Syphilis | ||||
ELISA | NT | Reactive | NT | Nonreactive |
Rapid plasma reagin | NT | Nonreactive | NT | Nonreactive |
Treponema pallidum particle agglutination assay | NT | Nonreactive | NT | Nonreactive |
INNO-LIA | NT | Negative | NT | Negative |
Hepatitis B | ||||
Hepatitis B surface antigen | Nonreactive | NT | NT | Nonreactive |
Anti-HBs | NT | NT | Reactive (titre 719.6 IU/L) | Reactive (titre 399.1 IU/L)‡ |
Anti-HBc (total) | NT | NT | Reactive | Nonreactive§ |
Note: anti-HBc = antibody to hepatitis B core protein, anti-HBs = antibody to hepatitis B surface antigen, ELISA = enzyme-linked immunosorbent assay, HTLV = human T-lymphotropic virus, INNO-LIA = commercially available line immunoassay, NT = not tested, RIPA = radioimmunoprecipitation assay.
↵* HTLV I/II ELISA was repeated on a serum sample obtained 2 wk before transfusion and was still nonreactive.
↵† HTLV I/II ELISA was repeated on a serum sample obtained 4 d later and was still reactive.
↵‡ Anti-HBs serology was repeated 4 mo later and was still reactive (titre 173.9 IU/L).
↵§ Anti-HBc serology was repeated 4 wk later and was still nonreactive.